title: [Treatment of allergic rhinitis].
abstract: The allergic rhinitis is the most common allergic condition. The causes of allergic rhinitis are still much debated, but there is now a consensus on the need to initiate treatment as early as possible in order to avoid the spreading of the infection to the bronchi. In addition to allergy prevention, the aim of treatment is medical control of the allergic inflammatory reaction and thus improvement of the clinical symptoms. Depending on the severity of the disease and the predominant symptoms, this can be achieved with mast cell stabilizers, local and systemic H1 antagonists, local steroids and anticholinergic drugs. The WHO also recommends hyposensitization, which may be subcutaneous (SIT) or sublingual (SLIT).
authors.forename: G
authors.initials: G
authors.lastname: Grevers
authors.forename: A
authors.initials: A
authors.lastname: Klemens
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D002648:Child; D003131:Combined Modality Therapy; D003888:Desensitization, Immunologic / Q000379:methods; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D007073:Immunoglobulin E / Q000097:blood; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D055502:Secondary Prevention
chemical_list: D018926:Anti-Allergic Agents; D007073:Immunoglobulin E